A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)

Inclusion Criteria:

- Diagnosis of asthma of at least 6 months duration.

- Using an Inhaled corticosteroid (ICS) - either alone or in combination with a
Long-acting beta-2 agonist (LABA) - for at least 12 weeks prior to the Screening
Visit and must have been on a stable asthma regimen for at least 2 weeks prior to the
Screening Visit, must not have used oral glucocorticosteroids within 30 days of the
Screening Visit.

Exclusion Criteria:

- Treated in the emergency room for a severe asthma exacerbation requiring systemic
glucocorticosteroid treatment, or hospitalization for management of airway
obstruction within 3 months prior to the Screening Visit.

- History of ventilator support for respiratory failure secondary to asthma.

- Upper or lower respiratory tract infection (viral or bacterial) within the 2 weeks
prior to Screening and Baseline Visits.

- History of clinically significant renal, hepatic, cardiovascular, metabolic,
neurologic, hematologic, ophthalmologic, respiratory, gastrointestinal,
cerebrovascular, or other significant medical illness or disorder which, in the

judgment of the investigator, could interfere with the study or require treatment that
might interfere with the study. Specific examples include but are not limited to
insulin-dependent diabetes, hypertension, active hepatitis, cardiovascular disease
including hypertension, or conditions that may interfere with respiratory function such
as, bronchiectasis, and cystic fibrosis. Other conditions that are well controlled and
stable will not prohibit participation if deemed appropriate per the investigator's
judgment.

- Allergy/sensitivity to glucocorticoids, beta-2 agonists, or study drug/excipients.

- Inability to correctly use an oral MDI or a DPI.

- Participation in this study at another investigational site. Participation in a
different investigational study at any site during the same timeframe of this study.

- Randomization into this study more than once.

- Direct association with either the administration of the this study or the study
staff.